Answers are grounded in this paper and cite their sources.
To compare cervical stroma in advanced cervical cancer with the control group; to compare, in the pre-treatment period, hemogram parameters in patients with advanced cervical cancer with the same parameters as the control group; and to verify if there is an association of stromal markers with prognostic factors in cervical cancer.
No takes yet. Share an insight, caveat, or question.
Otaño et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: